In Cancer Care, Cost Matters

When A Famous Hospital Didn’t Want An Expensive New Drug
by David Kestenbaum
March 28, 2013
http://www.npr.org/blogs/money/2013/03/28/175368440/when-a-famous-hospital-didnt-want-an-expensive-new-drug
comparative effectiveness
extends life for 1.4 months

ZALTRAP (ziv-aflibercept)
https://www.zaltrap.com
ZALTRAP®, in combination with 5-fluorouracil, leucovorin, irinotecan-(FOLFIRI), is indicated for patients with metastatic colorectal cancer (mCRC) that is resistant to or has progressed following an oxaliplatin-containing regimen.

In Cancer Care, Cost Matters  
By PETER B. BACH, LEONARD B. SALTZ and ROBERT E. WITTES
October 14, 2012
http://www.nytimes.com/2012/10/15/opinion/a-hospital-says-no-to-an-11000-a-month-cancer-drug.html

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s